US Vaccine Candidate Heads To Widespread Testing In People

A COVID-19 vaccine candidate developed by the US company Moderna and the National Institutes of Health starts its final phase of testing today. It’s one of a handful of candidates to reach this stage.

(Image credit: Maddie Meyer/Getty Images)

Source link